Sign in
RP Stock Price, Chart, Stats & News
RepliCel Life Sciences Inc.
Save
RepliCel Life Sciences Inc. (RP) does not currently pay a dividend.
1.10M
Market cap
–
Current P/E
–
Forward P/E
RP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically.
Similar securities
Based on sector and market capitalization
Report issue